Der observeredes en tendens til forbedret ORR hos patienter med 17p deletion behandlet med MabCampath (64% v 20%; p=0, 0805).
A trend toward improved ORR was observed in patients with 17p deletion treated with MabCampath (64% v 20%; p=0.0805).